Istanbul Medipol University Hospital
medipol.edu.trTotal trials
342
Active
54
Phase 3
0
Total enrollment
28,111
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Somatostatin | — | — | — | — | — | 1 | |
| Terlipressin | — | — | — | — | — | 1 |
Next readouts
- 2027-03-15
Top conditions
- Low Back Pain9
- Pain8
- Pulmonary Rehabilitation8
- Periodontitis8
- Exercise7
- Quality of Life7
- Pes Planus6
- Stroke6
Frequently asked questions about Istanbul Medipol University Hospital
- How many clinical trials does Istanbul Medipol University Hospital have on ClinicalTrials.gov?
- Istanbul Medipol University Hospital is listed as the lead sponsor on 342 clinical trials in ClinicalTrials.gov, 54 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istanbul Medipol University Hospital's trials are in Phase 3?
- 0 of Istanbul Medipol University Hospital's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Istanbul Medipol University Hospital focus on?
- Istanbul Medipol University Hospital's most-studied conditions on ClinicalTrials.gov are Low Back Pain, Pain, Pulmonary Rehabilitation, Periodontitis, Exercise.
- When are Istanbul Medipol University Hospital's next clinical trial readouts?
- Istanbul Medipol University Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation”, expected around 2027-03-15.